Romiplostim Reduces Platelet Transfusion Needs in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Romiplostim demonstrated an improved efficacy and a favorable safety profile compared to the conventional approach in patients undergoing ASCT.
Authors
- Neerja Kushwaha (ORCID: https://orcid.org/0000-0002-0998-9893)
- Bhupesh Guleria (ORCID: https://orcid.org/0000-0001-8308-8690)
- Gurjeet Singh Chowdhary (ORCID: https://orcid.org/0000-0002-2269-3579)
- Vijay Bohra (ORCID: https://orcid.org/0000-0002-3794-7316)
- Haranath Reddy Medapati Rama
- Dharmesh Soneji
- Jyotindu Debnath (ORCID: https://orcid.org/0000-0002-5466-8896)
- Vadlamani Surya Prakash
- Pankaj P. Rao (ORCID: https://orcid.org/0000-0002-1420-7622)
- Kundan Mishra (ORCID: https://orcid.org/0000-0002-6325-2972)
- Rajesh Nair (ORCID: https://orcid.org/0000-0003-1760-9608)
- Harshit Khurana (ORCID: https://orcid.org/0009-0009-6424-2563)
- Sanjeevan Sharma (ORCID: https://orcid.org/0000-0002-7553-8193)
- Amit Kumar Biswas (ORCID: https://orcid.org/0000-0002-6199-2205)
- Sandeep Thareja
Institutions
- Command Hospital (IN)
Publication Details
- Journal
- Cureus
- Published
- 2024-12-21
- DOI
- https://doi.org/10.7759/cureus.76164
- Citations
- 1
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.28